1. Home
  2. NL vs PALI Comparison

NL vs PALI Comparison

Compare NL & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NL Industries Inc.

NL

NL Industries Inc.

HOLD

Current Price

$6.11

Market Cap

283.9M

Sector

Industrials

ML Signal

HOLD

Logo Palisade Bio Inc.

PALI

Palisade Bio Inc.

HOLD

Current Price

$1.59

Market Cap

311.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NL
PALI
Founded
1891
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.9M
311.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NL
PALI
Price
$6.11
$1.59
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$15.00
AVG Volume (30 Days)
73.6K
5.9M
Earning Date
03-05-2026
11-10-2025
Dividend Yield
9.05%
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$159,004,000.00
N/A
Revenue This Year
$15.75
N/A
Revenue Next Year
$2.44
N/A
P/E Ratio
$31.75
N/A
Revenue Growth
5.52
N/A
52 Week Low
$5.04
$0.53
52 Week High
$9.27
$2.64

Technical Indicators

Market Signals
Indicator
NL
PALI
Relative Strength Index (RSI) 53.82 39.90
Support Level $5.95 $1.64
Resistance Level $6.45 $1.96
Average True Range (ATR) 0.40 0.16
MACD -0.00 -0.03
Stochastic Oscillator 49.19 4.35

Price Performance

Historical Comparison
NL
PALI

About NL NL Industries Inc.

NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

About PALI Palisade Bio Inc.

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Share on Social Networks: